The Cypriot legal framework distinguishes between industrial hemp and narcotic cannabis. CBD is considered a medicine in Cyprus and any CBD-infused product would be classified as a medicinal product. Due to its status as a medicine, CBD cannot be used in cosmetics, vaping products, food or pet food. This report offers a comprehensive guide to the current regulatory framework in place for CBD and it’s related products, as well as medical and recreational cannabis.
Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.
Europe’s still asking questions about novel food submission
A year and eight months after Cibdol submitted its novel food application for EU authorisation of synthetically produced CBD, the Swiss company is still fielding questions from the European Food Safety Authority (ESFA)
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
Table of contents